BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients. Biol Proced Online 2020;22:18. [PMID: 32728349 DOI: 10.1186/s12575-020-00131-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Shen Y, Yu F, Zhang D, Zou Q, Xie M, Chen X, Yuan L, Lou B, Xie G, Wang R, Yang X, Chen W, Wang Q, Feng B, Teng Y, Dong Y, Huang L, Bao J, Han D, Liu C, Wu W, Liu X, Fan L, Timko MP, Zheng S, Chen Y. Dynamic Alterations in the Respiratory Tract Microbiota of Patients with COVID-19 and its Association with Microbiota in the Gut. Adv Sci (Weinh) 2022;:e2200956. [PMID: 35780499 DOI: 10.1002/advs.202200956] [Reference Citation Analysis]
2 Kolhe R, Sahajpal NS, Vyavahare S, Dhanani AS, Adusumilli S, Ananth S, Mondal AK, Patterson GT, Kumar S, Rojiani AM, Isales CM, Fulzele S. Alteration in Nasopharyngeal Microbiota Profile in Aged Patients with COVID-19. Diagnostics (Basel) 2021;11:1622. [PMID: 34573964 DOI: 10.3390/diagnostics11091622] [Reference Citation Analysis]
3 Lichtenstein M, Turjerman S, Pinto JM, Barash O, Koren O. Pathophysiology of SARS-CoV-2 Infection in the Upper Respiratory Tract and Its Relation to Breath Volatile Organic Compounds. mSystems 2021;6:e0010421. [PMID: 34313463 DOI: 10.1128/mSystems.00104-21] [Reference Citation Analysis]
4 Hong BS, Kim MR. Interplays between human microbiota and microRNAs in COVID-19 pathogenesis: a literature review. Phys Act Nutr 2021;25:1-7. [PMID: 34315200 DOI: 10.20463/pan.2021.0008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Braun T, Halevi S, Hadar R, Efroni G, Glick Saar E, Keller N, Amir A, Amit S, Haberman Y. SARS-CoV-2 does not have a strong effect on the nasopharyngeal microbial composition. Sci Rep 2021;11:8922. [PMID: 33903709 DOI: 10.1038/s41598-021-88536-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ventero MP, Cuadrat RRC, Vidal I, Andrade BGN, Molina-Pardines C, Haro-Moreno JM, Coutinho FH, Merino E, Regitano LCA, Silveira CB, Afli H, López-Pérez M, Rodríguez JC. Nasopharyngeal Microbial Communities of Patients Infected With SARS-CoV-2 That Developed COVID-19. Front Microbiol 2021;12:637430. [PMID: 33815323 DOI: 10.3389/fmicb.2021.637430] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rocafort M, Henares D, Brotons P, Launes C, Fernandez de Sevilla M, Fumado V, Barrabeig I, Arias S, Redin A, Ponomarenko J, Mele M, Millat-martinez P, Claverol J, Balanza N, Mira A, Garcia-garcia JJ, Bassat Q, Jordan I, Muñoz-almagro C. Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home. Viruses 2022;14:1521. [DOI: 10.3390/v14071521] [Reference Citation Analysis]
8 Feehan AK, Rose R, Nolan DJ, Spitz AM, Graubics K, Colwell RR, Garcia-diaz J, Lamers SL. Nasopharyngeal Microbiome Community Composition and Structure Is Associated with Severity of COVID-19 Disease and Breathing Treatment. Applied Microbiology 2021;1:177-88. [DOI: 10.3390/applmicrobiol1020014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ferrari L, Favero C, Solazzo G, Mariani J, Luganini A, Ferraroni M, Montomoli E, Milani GP, Bollati V; UNICORN Consortium. Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects. Front Cell Infect Microbiol 2022;12:882302. [DOI: 10.3389/fcimb.2022.882302] [Reference Citation Analysis]
10 Di Stadio A, Costantini C, Renga G, Pariano M, Ricci G, Romani L. The Microbiota/Host Immune System Interaction in the Nose to Protect from COVID-19. Life (Basel) 2020;10:E345. [PMID: 33322584 DOI: 10.3390/life10120345] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
11 Yamamoto S, Saito M, Tamura A, Prawisuda D, Mizutani T, Yotsuyanagi H. The human microbiome and COVID-19: A systematic review. PLoS One 2021;16:e0253293. [PMID: 34161373 DOI: 10.1371/journal.pone.0253293] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Gao M, Wang H, Luo H, Sun Y, Wang L, Ding S, Ren H, Gang J, Rao B, Liu S, Wang X, Gao X, Li M, Zou Y, Liu C, Yuan C, Sun J, Cui G, Ren Z. Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients. Adv Sci (Weinh) 2021;8:e2102785. [PMID: 34423593 DOI: 10.1002/advs.202102785] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V. Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention. J Inflamm Res 2021;14:6349-81. [PMID: 34876830 DOI: 10.2147/JIR.S333887] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ma S, Zhang F, Zhou F, Li H, Ge W, Gan R, Nie H, Li B, Wang Y, Wu M, Li D, Wang D, Wang Z, You Y, Huang Z. Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Signal Transduct Target Ther 2021;6:191. [PMID: 33986253 DOI: 10.1038/s41392-021-00614-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Devi P, Maurya R, Mehta P, Shamim U, Yadav A, Chattopadhyay P, Kanakan A, Khare K, Vasudevan JS, Sahni S, Mishra P, Tyagi A, Jha S, Budhiraja S, Tarai B, Pandey R. Increased Abundance of Achromobacter xylosoxidans and Bacillus cereus in Upper Airway Transcriptionally Active Microbiome of COVID-19 Mortality Patients Indicates Role of Co-Infections in Disease Severity and Outcome. Microbiol Spectr 2022;:e0231121. [PMID: 35579429 DOI: 10.1128/spectrum.02311-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 De Pascale G, De Maio F, Carelli S, De Angelis G, Cacaci M, Montini L, Bello G, Cutuli SL, Pintaudi G, Tanzarella ES, Xhemalaj R, Grieco DL, Tumbarello M, Sanguinetti M, Posteraro B, Antonelli M. Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosis. Crit Care 2021;25:197. [PMID: 34099016 DOI: 10.1186/s13054-021-03623-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Rhoades NS, Pinski AN, Monsibais AN, Jankeel A, Doratt BM, Cinco IR, Ibraim I, Messaoudi I. Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose. Cell Rep 2021;36:109637. [PMID: 34433082 DOI: 10.1016/j.celrep.2021.109637] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wang H, Wang H, Sun Y, Ren Z, Zhu W, Li A, Cui G. Potential Associations Between Microbiome and COVID-19. Front Med (Lausanne) 2021;8:785496. [PMID: 35004750 DOI: 10.3389/fmed.2021.785496] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
19 Crovetto F, Selma-Royo M, Crispi F, Carbonetto B, Pascal R, Larroya M, Casas I, Tortajada M, Escudero N, Muñoz-Almagro C, Gomez-Roig MD, González-Torres P, Collado MC, Gratacos E. Nasopharyngeal microbiota profiling of pregnant women with SARS-CoV-2 infection. Sci Rep 2022;12:13404. [PMID: 35927569 DOI: 10.1038/s41598-022-17542-z] [Reference Citation Analysis]
20 Ventero MP, Moreno-Perez O, Molina-Pardines C, Paytuví-Gallart A, Boix V, Escribano I, Galan I, González-delaAleja P, López-Pérez M, Sánchez-Martínez R, Merino E, Rodríguez JC. Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area. J Infect 2021:S0163-4453(21)00647-2. [PMID: 34963638 DOI: 10.1016/j.jinf.2021.12.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Liu TFD, Philippou E, Kolokotroni O, Siakallis G, Rahima K, Constantinou C. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review. Infection 2021. [PMID: 34671922 DOI: 10.1007/s15010-021-01715-5] [Reference Citation Analysis]
22 Castañeda-Mogollón D, Kamaliddin C, Oberding L, Liu Y, Mohon AN, Faridi RM, Khan F, Pillai DR. A metagenomics workflow for SARS-CoV-2 identification, co-pathogen detection, and overall diversity. J Clin Virol 2021;145:105025. [PMID: 34775144 DOI: 10.1016/j.jcv.2021.105025] [Reference Citation Analysis]
23 Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections. Arch Dis Child 2020:archdischild-2020-320338. [PMID: 33262177 DOI: 10.1136/archdischild-2020-320338] [Cited by in Crossref: 50] [Cited by in F6Publishing: 61] [Article Influence: 25.0] [Reference Citation Analysis]
24 Seibert B, Cáceres CJ, Cardenas-Garcia S, Carnaccini S, Geiger G, Rajao DS, Ottesen E, Perez DR. Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model. Microbiol Spectr 2021;9:e0053621. [PMID: 34378965 DOI: 10.1128/Spectrum.00536-21] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Ng DL, Granados AC, Santos YA, Servellita V, Goldgof GM, Meydan C, Sotomayor-Gonzalez A, Levine AG, Balcerek J, Han LM, Akagi N, Truong K, Neumann NM, Nguyen DN, Bapat SP, Cheng J, Martin CS, Federman S, Foox J, Gopez A, Li T, Chan R, Chu CS, Wabl CA, Gliwa AS, Reyes K, Pan CY, Guevara H, Wadford D, Miller S, Mason CE, Chiu CY. A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood. Sci Adv 2021;7:eabe5984. [PMID: 33536218 DOI: 10.1126/sciadv.abe5984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
26 Giugliano R, Sellitto A, Ferravante C, Rocco T, D'agostino Y, Alexandrova E, Lamberti J, Palumbo D, Galdiero M, Vaccaro E, Pagliano P, Weisz A, Giurato G, Franci G, Rizzo F. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy. Microbial Pathogenesis 2022;165:105506. [DOI: 10.1016/j.micpath.2022.105506] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Thangaleela S, Sivamaruthi BS, Kesika P, Bharathi M, Chaiyasut C. Nasal Microbiota, Olfactory Health, Neurological Disorders and Aging—A Review. Microorganisms 2022;10:1405. [DOI: 10.3390/microorganisms10071405] [Reference Citation Analysis]
28 Nardelli C, Gentile I, Setaro M, Di Domenico C, Pinchera B, Buonomo AR, Zappulo E, Scotto R, Scaglione GL, Castaldo G, Capoluongo E. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? Front Cell Infect Microbiol 2021;11:625581. [PMID: 33659220 DOI: 10.3389/fcimb.2021.625581] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
29 Rosas-Salazar C, Kimura KS, Shilts MH, Strickland BA, Freeman MH, Wessinger BC, Gupta V, Brown HM, Rajagopala SV, Turner JH, Das SR. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome. J Allergy Clin Immunol 2021;147:1226-1233.e2. [PMID: 33577896 DOI: 10.1016/j.jaci.2021.02.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
30 Shilts MH, Rosas-salazar C, Strickland BA, Kimura KS, Asad M, Sehanobish E, Freeman MH, Wessinger BC, Gupta V, Brown HM, Boone HH, Patel V, Barbi M, Bottalico D, O’neill M, Akbar N, Rajagopala SV, Mallal S, Phillips E, Turner JH, Jerschow E, Das SR. Severe COVID-19 Is Associated With an Altered Upper Respiratory Tract Microbiome. Front Cell Infect Microbiol 2022;11:781968. [DOI: 10.3389/fcimb.2021.781968] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
31 Falahi S, Abdoli A, Kenarkoohi A. Claims and reasons about mild COVID-19 in children. New Microbes New Infect 2021;41:100864. [PMID: 33747533 DOI: 10.1016/j.nmni.2021.100864] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Islam MA, Albarracin L, Melnikov V, Andrade BGN, Cuadrat RRC, Kitazawa H, Villena J. Dolosigranulum pigrum Modulates Immunity against SARS-CoV-2 in Respiratory Epithelial Cells. Pathogens 2021;10:634. [PMID: 34064210 DOI: 10.3390/pathogens10060634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Soltani S, Zakeri A, Zandi M, Kesheh MM, Tabibzadeh A, Dastranj M, Faramarzi S, Didehdar M, Hafezi H, Hosseini P, Farahani A. The Role of Bacterial and Fungal Human Respiratory Microbiota in COVID-19 Patients. Biomed Res Int 2021;2021:6670798. [PMID: 33681368 DOI: 10.1155/2021/6670798] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
34 de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRB. Microbiota Modulation of the Gut-Lung Axis in COVID-19. Front Immunol 2021;12:635471. [PMID: 33717181 DOI: 10.3389/fimmu.2021.635471] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
35 Cyprian F, Sohail MU, Abdelhafez I, Salman S, Attique Z, Kamareddine L, Al-Asmakh M. SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections. Int J Infect Dis 2021;105:540-50. [PMID: 33610778 DOI: 10.1016/j.ijid.2021.02.071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Tchoupou Saha OF, Dubourg G, Yacouba A, Bossi V, Raoult D, Lagier JC. Profile of the Nasopharyngeal Microbiota Affecting the Clinical Course in COVID-19 Patients. Front Microbiol 2022;13:871627. [PMID: 35655997 DOI: 10.3389/fmicb.2022.871627] [Reference Citation Analysis]
37 Desai S, Rashmi S, Rane A, Dharavath B, Sawant A, Dutt A. An integrated approach to determine the abundance, mutation rate and phylogeny of the SARS-CoV-2 genome. Brief Bioinform 2021;22:1065-75. [PMID: 33479725 DOI: 10.1093/bib/bbaa437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
38 Prasad P, Mahapatra S, Mishra R, Murmu KC, Aggarwal S, Sethi M, Mohapatra P, Ghosh A, Yadav R, Dodia H, Ansari SA, De S, Singh D, Suryawanshi A, Dash R, Senapati S, Beuria TK, Chattopadhyay S, Syed GH, Swain R, Raghav SK, Parida A. Long-read 16S-seq reveals nasopharynx microbial dysbiosis and enrichment of Mycobacterium and Mycoplasma in COVID-19 patients: a potential source of co-infection. Mol Omics 2022. [PMID: 35506682 DOI: 10.1039/d2mo00044j] [Reference Citation Analysis]
39 Gupta A, Karyakarte R, Joshi S, Das R, Jani K, Shouche Y, Sharma A. Nasopharyngeal microbiome reveals the prevalence of opportunistic pathogens in SARS-CoV-2 infected individuals and their association with host types. Microbes Infect 2021;:104880. [PMID: 34425246 DOI: 10.1016/j.micinf.2021.104880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
40 Bai X, Narayanan A, Skagerberg M, Ceña-Diez R, Giske CG, Strålin K, Sönnerborg A. Characterization of the Upper Respiratory Bacterial Microbiome in Critically Ill COVID-19 Patients. Biomedicines 2022;10:982. [PMID: 35625719 DOI: 10.3390/biomedicines10050982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ezechukwu HC, Diya CA, Egoh IJ, Abiodun MJ, Grace JA, Okoh GR, Adu KT, Adegboye OA. Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy. Ther Adv Infect Dis 2021;8:20499361211032453. [PMID: 35035953 DOI: 10.1177/20499361211032453] [Reference Citation Analysis]
42 Engen PA, Naqib A, Jennings C, Green SJ, Landay A, Keshavarzian A, Voigt RM. Nasopharyngeal Microbiota in SARS-CoV-2 Positive and Negative Patients. Biol Proced Online 2021;23:10. [PMID: 34058978 DOI: 10.1186/s12575-021-00148-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rhoades NS, Pinski A, Monsibais AN, Jankeel A, Doratt BM, Cinco IR, Ibraim I, Messaoudi I. Acute SARS-CoV-2 infection is associated with an expansion of bacteria pathogens in the nose including Pseudomonas Aeruginosa. bioRxiv 2021:2021. [PMID: 34031657 DOI: 10.1101/2021.05.20.445008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]